Showing results (1151-1160 of 1,538) with videos related to

Sort By:
Pageof 154
Scientific Reports|January 7, 2026
Randomised controlled trial of online behavioural sleep intervention for children with epilepsyPaul Gringras, Aiswarya Anilkumar, Lucy Bray, et al.
JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinomaB I Rini, L Albiges, X Tang, et al.
American Journal of Human Genetics|November 9, 2004
Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsyDavid A Greenberg, Eftihia Cayanis, Lisa Strug, et al.
JAMA Network Open|March 20, 2025
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the USZeynep Irem Ozay, Yeonjung Jo, Gliceida Galarza Fortuna, et al.
Plos One|May 3, 2013
Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disordersMaria Tropeano, Joo Wook Ahn, Richard J B Dobson, et al.
Investigational New Drugs|August 22, 2014
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinomaNizar M Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, et al.
Multiple Sclerosis and Related Disorders|March 20, 2022
COVID-19 vaccine associated demyelination & its association with MOG antibodyM Netravathi, Kamakshi Dhamija, Manisha Gupta, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Journal for Immunotherapy of Cancer|August 22, 2023
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancerJonathan Anker, Sumanta K Pal, Seunghee Kim-Schulze, et al.
Pageof 154